Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy

BACKGROUND: Treating patients with end-stage diffuse coronary artery disease (EnD-CAD) unsuitable for coronary intervention remains a clinical challenge. They usually express refractory angina and have a high risk of mortality. Although growing data have indicated cell therapy is an alternative solu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pei-Hsun, Chiang, Hsin-Ju, Li, Yi-Chen, Chiang, John Y., Chu, Chi-Hsiang, Shao, Pei-Lin, Lee, Fan-Yen, Lee, Mel S., Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391819/
https://www.ncbi.nlm.nih.gov/pubmed/32727585
http://dx.doi.org/10.1186/s13287-020-01835-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391819/
https://www.ncbi.nlm.nih.gov/pubmed/32727585
http://dx.doi.org/10.1186/s13287-020-01835-z

Ejemplares similares